The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Patel Sailash since 2014.
The trader's CIK number is 1590795.
At the time of the last reporting, Patel Sailash was the Chief Financial Officer of Furiex Pharmaceuticals, Inc.. (stock ticker symbol FURX).
Also see all insider trading activities at Furiex Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | FURX | 0 | $0 | 32,928 | $3,424,512 | 32,928 | $299,974 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-24 | FURX | Option Ex | 32,928 | 9.11 | 299,974 |
| 2014-06-24 | FURX | Sale | 32,928 | 104.00 | 3,424,512 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Sailash (Chief Financial Officer of Furiex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.